ImmunOs
8 known investors
Find your way into ImmunOs
Sign up to see every warm intro you have to ImmunOs
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ImmunOs team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Immunos Therapeutics develops therapies for immuno-oncology and inflammatory diseases. The company focuses on advancing treatments in cancer immunotherapy and inflammation-related conditions.
Investors · 8
How we know: Backbone Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: BioMedPartners's portfolio page · press coverage · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Lightspeed Venture Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Mission Biocapital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Pfizer Venture Investments's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Related companies · 5
Companies working in the same space as ImmunOs.
In the news
Frequently asked questions
- What does ImmunOs do?
- Immunos Therapeutics develops therapies for immuno-oncology and inflammatory diseases. The company focuses on advancing treatments in cancer immunotherapy and inflammation-related conditions.
- Who are ImmunOs's investors?
- ImmunOs's investors include Backbone Ventures, BioMedPartners, Gimv, Lightspeed Venture Partners, Mission Biocapital, Pfizer Venture Investments, Pfizer Ventures, redalpine.






